Its breadth of mechanisms, excellent oral viability in the arginate form, and compatibility with other healing peptides make it the most versatile option in the category
Currently, the BPC-157 peptide is not FDA-approved, and research is ongoing regarding its medical applications
To the best of our knowledge, this represents the first real-world experience with Polmacoxib 2 mg in this patient population
BPC-157, a stable gastric pentadecapeptide, works primarily through angiogenic (blood vessel formation) and nitric oxide pathways, showing particular efficacy in gastrointestinal, tendon, and ligament healing in animal models
The cause of B12 deficiency, vegetarian diet, pregnancy, and breastfeeding, can impact the dosage and duration of therapy
10.3109/07853890109002083 17 BrcicL.BrcicI.StaresinicM.NovinscakT.SikiricP.SeiwerthS